Friday, September 20, 2024 7:56:04 PM
$RDGL Trend Continues Higher High's Higher Low's Higher Close's
Date***********Close**High***Low*******Volume
20 Sept 2024 0.1634 0.1678 0.1575***** 645,738
19 Sept 2024 0.1598 0.1645 0.1510***** 506,525
18 Sept 2024 0.1562 0.1622 0.1505*** 1,125,259
17 Sept 2024 0.1553 0.1583 0.1495***** 865,500
16 Sept 2024 0.1540 0.1574 0.1461***** 951,042
13 Sept 2024 0.1455 0.1545 0.1338*** 1,095,701
12 Sept 2024 0.1355 0.1450 0.1331***** 805,270
11 Sept 2024 0.1420 0.1465 0.1386***** 267,709
10 Sept 2024 0.1414 0.1503 0.1300*** 1,553,373
09 Sept 2024 0.1301 0.1420 0.1230*** 1,317,001
06 Sept 2024 0.1230 0.1270 0.1175***** 553,374
05 Sept 2024 0.1210 0.1259 0.1080*** 1,099,808
04 Sept 2024 0.1186 0.1840 0.1030*** 6,309,957 >>>>News of FDA re-submission delay
03 Sept 2024 0.1516 0.1579 0.1339*** 1,112,67
https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/historical
Date***********Close**High***Low*******Volume
20 Sept 2024 0.1634 0.1678 0.1575***** 645,738
19 Sept 2024 0.1598 0.1645 0.1510***** 506,525
18 Sept 2024 0.1562 0.1622 0.1505*** 1,125,259
17 Sept 2024 0.1553 0.1583 0.1495***** 865,500
16 Sept 2024 0.1540 0.1574 0.1461***** 951,042
13 Sept 2024 0.1455 0.1545 0.1338*** 1,095,701
12 Sept 2024 0.1355 0.1450 0.1331***** 805,270
11 Sept 2024 0.1420 0.1465 0.1386***** 267,709
10 Sept 2024 0.1414 0.1503 0.1300*** 1,553,373
09 Sept 2024 0.1301 0.1420 0.1230*** 1,317,001
06 Sept 2024 0.1230 0.1270 0.1175***** 553,374
05 Sept 2024 0.1210 0.1259 0.1080*** 1,099,808
04 Sept 2024 0.1186 0.1840 0.1030*** 6,309,957 >>>>News of FDA re-submission delay
03 Sept 2024 0.1516 0.1579 0.1339*** 1,112,67
https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/historical
Never buy a stock based on my opinion of that stock.Form your own opinion by doing your own DD.My position on any stock I buy can change without notice.I am not a licensed broker or stock adviser and I really don't know what I'm doing.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
